0001225208-17-016427.txt : 20171020
0001225208-17-016427.hdr.sgml : 20171020
20171020101428
ACCESSION NUMBER: 0001225208-17-016427
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171018
FILED AS OF DATE: 20171020
DATE AS OF CHANGE: 20171020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lupisella Frank Jr
CENTRAL INDEX KEY: 0001361680
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06926
FILM NUMBER: 171146175
MAIL ADDRESS:
STREET 1: C R BARD INC 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BARD C R INC /NJ/
CENTRAL INDEX KEY: 0000009892
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 221454160
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
BUSINESS PHONE: 9082778000
MAIL ADDRESS:
STREET 1: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
4
1
doc4.xml
X0306
4
2017-10-18
0000009892
BARD C R INC /NJ/
BCR
0001361680
Lupisella Frank Jr
C/O C. R. BARD, INC.
730 CENTRAL AVENUE
MURRAY HILL
NJ
07974
1
Vice President and Controller
Common Stock
2017-10-18
4
M
0
5710.0000
97.6850
A
15879.0488
D
Common Stock
2017-10-18
4
M
0
3463.0000
84.5750
A
19342.0488
D
Common Stock
2017-10-18
4
S
0
9173.0000
325.0002
D
10169.0488
D
Common Stock
1100.2220
I
401(k) Plan
Option (Right to Buy)
97.6850
2017-10-18
4
M
0
5710.0000
0.0000
D
2022-12-12
Common Stock
5710.0000
0.0000
D
Option (Right to Buy)
84.5750
2017-10-18
4
M
0
3463.0000
0.0000
D
2021-12-14
Common Stock
3463.0000
0.0000
D
Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
Includes 0.0015 shares acquired under the Company's Dividend Reinvestment Plan from February 4, 2017 to August 4, 2017. Includes 30.361 shares acquired under the Company's Employee Stock Purchase Plan from February 7, 2017 to August 7, 2017.
Represents the weighted average sales price for price increments ranging from $325.00 to $325.02. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Includes 0.566 shares acquired under the Company's 401(k) Plan from February 4, 2017 to August 4, 2017.
Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Options fully vested and are currently exercisable.
Options granted under 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Myra McGinley, Attorney-in-Fact
2017-10-20